• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Incidence of Waldenström's macroglobulinemia.

作者信息

Herrinton L J, Weiss N S

机构信息

Department of Epidemiology, University of Washington, Seattle.

出版信息

Blood. 1993 Nov 15;82(10):3148-50.

PMID:8219203
Abstract

This study sought to determine the incidence and pattern of occurrence of Waldenström's macroglobulinemia, a plasmacytoid lymphocyte malignancy that involves monoclonal production of the IgM M-component type. Cases with Waldenström's macroglobulinemia have been reported since 1978 to the population-based cancer registry that serves western Washington state, and since 1988 to the eight other cancer registries that participate in the National Cancer Institute's Surveillance, Epidemiology, and End-Results program. Persons less than 85 years old newly diagnosed with Waldenström's macroglobulinemia were identified through 1989. The age-standardized annual incidence rate was 6.1 per million in white men and 2.5 per million in white women (1980 US standard). Only five cases were reported in black women, among whom the age-standardized annual incidence rate was 3.6 per million. No cases were reported among black men (5.8 cases expected, based on the rates in white men); this finding may be due to chance, underdiagnosis of Waldenström's macroglobulinemia in this group, or may reflect a truly low rate. Further investigation of a large, racially diverse population is required to better characterize the epidemiology of this rare disease.

摘要

相似文献

1
Incidence of Waldenström's macroglobulinemia.
Blood. 1993 Nov 15;82(10):3148-50.
2
Incidence of lymphoplasmacytic lymphoma/Waldenström's macroglobulinaemia in Japan and Taiwan population-based cancer registries, 1996-2003.1996-2003 年日本和中国台湾地区人群癌症登记处淋巴浆细胞淋巴瘤/华氏巨球蛋白血症的发病情况。
Int J Cancer. 2014 Jan 1;134(1):174-80. doi: 10.1002/ijc.28343. Epub 2013 Jul 16.
3
Monoclonal gammopathy of undetermined significance and Waldenström's macroglobulinemia.意义未明的单克隆丙种球蛋白病和华氏巨球蛋白血症。
Best Pract Res Clin Haematol. 2016 Jun;29(2):187-193. doi: 10.1016/j.beha.2016.08.015. Epub 2016 Sep 4.
4
IgA and IgG hypogammaglobulinemia in Waldenström's macroglobulinemia.华氏巨球蛋白血症中的 IgA 和 IgG 低丙种球蛋白血症。
Haematologica. 2010 Mar;95(3):470-5. doi: 10.3324/haematol.2009.010348. Epub 2009 Nov 10.
5
Bilateral, persistent serous macular detachments with Waldenström's macroglobulinemia.双侧持续性浆液性黄斑脱离伴华氏巨球蛋白血症。
Optom Vis Sci. 2005 Jul;82(7):573-8. doi: 10.1097/01.opx.0000171333.64652.a4.
6
Waldenström's macroglobulinemia: incidence patterns in the United States, 1988-1994.
Cancer. 1998 Mar 15;82(6):1078-81.
7
Familial Waldenstrom's macroglobulinemia and relation to immune defects, autoimmune diseases, and haematological malignancies--A population-based study from northern Sweden.家族性华氏巨球蛋白血症及其与免疫缺陷、自身免疫性疾病和血液系统恶性肿瘤的关系——来自瑞典北部的一项基于人群的研究。
Acta Oncol. 2016;55(1):91-8. doi: 10.3109/0284186X.2015.1096019. Epub 2015 Nov 11.
8
Hepatocellular carcinoma followed by Waldenström's macroglobulinemia: a case report.肝细胞癌继发华氏巨球蛋白血症:一例报告
Hepatogastroenterology. 2000 May-Jun;47(33):842-5.
9
Novel agents in the treatment of Waldenström's macroglobulinemia.治疗华氏巨球蛋白血症的新型药物
Clin Lymphoma Myeloma. 2007 Aug;7 Suppl 5:S199-206. doi: 10.3816/clm.2007.s.023.
10
MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.瓦尔登斯特伦巨球蛋白血症中的 MYD88 L265P 体细胞突变。
N Engl J Med. 2012 Aug 30;367(9):826-33. doi: 10.1056/NEJMoa1200710.

引用本文的文献

1
Ocular complications of plasma cell dyscrasias.浆细胞异常相关的眼部并发症。
Eur J Ophthalmol. 2023 Sep;33(5):1786-1800. doi: 10.1177/11206721231155974. Epub 2023 Feb 9.
2
Revealing the Role of the Arg and Lys in Shifting Paradigm from BTK Selective Inhibition to the BTK/HCK Dual Inhibition - Delving into the Inhibitory Activity of KIN-8194 against BTK, and HCK in the Treatment of Mutated Waldenström Macroglobulinemia: A Computational Approach.揭示 Arg 和 Lys 在从 BTK 选择性抑制到 BTK/HCK 双重抑制转变中的作用 - 探讨 KIN-8194 对 BTK 和 HCK 的抑制活性在治疗突变型 Waldenström 巨球蛋白血症中的作用:一种计算方法。
Anticancer Agents Med Chem. 2024;24(11):813-825. doi: 10.2174/1871520623666230208102609.
3
Coming of Age for BTK Inhibitor Therapy: A Review of Zanubrutinib in Waldenström Macroglobulinemia.
BTK 抑制剂治疗时代的到来:泽布替尼治疗华氏巨球蛋白血症的综述。
Cells. 2022 Oct 19;11(20):3287. doi: 10.3390/cells11203287.
4
Multimodal Imaging of Waldenstrom Macroglobulinemia-Associated Hyperviscosity-Related Retinopathy Treated with Plasmapheresis.采用血浆置换治疗的华氏巨球蛋白血症相关高黏滞性视网膜病变的多模态成像
Case Rep Ophthalmol Med. 2021 Dec 15;2021:6816195. doi: 10.1155/2021/6816195. eCollection 2021.
5
Vitreous haemorrhage as the first presentation of undiagnosed Waldenstrom macroglobulinemia.玻璃体积血作为未确诊的华氏巨球蛋白血症的首发表现。
Int J Ophthalmol. 2021 Oct 18;14(10):1639-1641. doi: 10.18240/ijo.2021.10.25. eCollection 2021.
6
Current and novel BTK inhibitors in Waldenström's macroglobulinemia.华氏巨球蛋白血症中当前及新型布鲁顿酪氨酸激酶抑制剂
Ther Adv Hematol. 2021 Feb 7;12:2040620721989586. doi: 10.1177/2040620721989586. eCollection 2021.
7
Incidence, prevalence, mortality, and causes of death in Waldenström macroglobulinemia: a nationwide, population-based cohort study.华氏巨球蛋白血症的发病率、患病率、死亡率和死亡原因:一项全国性、基于人群的队列研究。
BMC Cancer. 2020 Jul 3;20(1):623. doi: 10.1186/s12885-020-07120-9.
8
Gene Expression Profiling Reveals Aberrant T-cell Marker Expression on Tumor Cells of Waldenström's Macroglobulinemia.基因表达谱分析揭示瓦尔登斯特伦巨球蛋白血症肿瘤细胞上 T 细胞标志物表达异常。
Clin Cancer Res. 2019 Jan 1;25(1):201-209. doi: 10.1158/1078-0432.CCR-18-1435. Epub 2018 Oct 2.
9
True, true unrelated? Coexistence of Waldenström macroglobulinemia and cardiac transthyretin amyloidosis.真的,真的不相关吗?华氏巨球蛋白血症与心脏转甲状腺素蛋白淀粉样变性共存。
Haematologica. 2018 Aug;103(8):e374-e376. doi: 10.3324/haematol.2018.190405. Epub 2018 Apr 19.
10
Allogeneic Transplantation for Relapsed Waldenström Macroglobulinemia and Lymphoplasmacytic Lymphoma.异基因移植治疗复发的华氏巨球蛋白血症和淋巴浆细胞淋巴瘤。
Biol Blood Marrow Transplant. 2017 Jan;23(1):60-66. doi: 10.1016/j.bbmt.2016.10.010. Epub 2016 Oct 24.